Skip to main content

Advertisement

Springer Nature Link
Log in

Interaction of Taspine Derivative TPD7 with Vascular Endothelial Growth Factor Receptor 2 by Cell Membrane Chromatography

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Affinity chromatography, as one of the important tools for studying the binding affinity between ligands and receptors, plays a key role in the process of screening and analyzing active compounds. Cell membrane chromatography (CMC) utilizes cell membrane receptors as stationary phases to perform screening and binding affinity of compounds with specific receptors whose three-dimensional configurations and biological activities were largely retained. In this study, a highly vascular endothelial growth factor receptor 2 (VEGFR2) expressing CMC method was established to investigate the binding affinity between TPD7 and VEGFR2. Competitive binding study taking sunitinib malate as the marker was used to inspect the binding site of TPD7 on VEGFR2. Results showed that TPD7 shared the same binding site with sunitinib on VEGFR2, which was consistent with the results of molecular docking. The equilibrium dissociation constants (KD) of TPD7 was (0.29 ± 0.02) × 10−6 M. Furthermore, TPD7 could alter the VEGFR2 kinase and significantly decrease phosphorylation of VEGFR2 in a dose-dependent manner. The studies showed that TPD7 could bind to VEGFR2 and then down-regulate the phosphorylation of VEGFR2.

Graphic Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669

    Article  CAS  Google Scholar 

  2. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677–1683

    CAS  PubMed  Google Scholar 

  3. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5:519–524

    CAS  PubMed  Google Scholar 

  4. Huang X, Zhou G, Wu W, Ma G, D’Amore PA, Mukai S, Lei H (2017) Editing VEGFR2 blocks VEGF-induced activation of Akt and tube formation. Investig Ophthalmol Vis Sci 58:1228–1236

    Article  CAS  Google Scholar 

  5. Liu Z, Qi L, Li Y, Zhao X, Sun B (2017) VEGFR2 regulates endothelial differentiation of colon cancer cells. BMC Cancer 17:593

    Article  Google Scholar 

  6. Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795–803

    Article  CAS  Google Scholar 

  7. Hajari Taheri F, Hassani M, Sharifzadeh Z, Behdani M, Arashkia A, Abolhassani M (2019) T cell engineered with a novel nanobody-based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy. IUBMB Life. https://doi.org/10.1002/iub

    Article  PubMed  Google Scholar 

  8. Lanitis E, Irving M, Coukos G (2015) Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol 33:55–63

    Article  CAS  Google Scholar 

  9. Padró T, Bieker R, Ruiz S, Steins M, Retzlaff S, Bürger H, Büchner T, Kessler T, Herrera F, Kienast J (2002) Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia 16:1302–1310

    Article  Google Scholar 

  10. Kanagawa N, Yanagawa T, Nakagawa T, Okada N, Nakagawa S (2013) Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy. Cancer Gene Ther 20:57–64

    Article  CAS  Google Scholar 

  11. Kolch W (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351(Pt 2):289–305

    Article  CAS  Google Scholar 

  12. Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2:a006502

    Article  Google Scholar 

  13. Farzaneh Behelgardi M, Zahri S, Mashayekhi F, Mansouri K, Asghari SM (2018) A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis. Sci Rep 8:17924

    Article  Google Scholar 

  14. Zheng X, Zhang Y, Zhang L, Xu W, Ma W, Sun R, Zeng H (2016) Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation. Biomed Pharmacother 83:212–220

    Article  CAS  Google Scholar 

  15. Li YP, He L (2007) Establishment of the model of vascular endothelial cell membrane chromatography and its preliminary application. Chin Sci Bull 52:922–928

    Article  CAS  Google Scholar 

  16. Zhang Y, He L, Meng L, Luo W (2008) Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation. Vasc Pharmacol 48:129–137

    Article  CAS  Google Scholar 

  17. Zhao J, Zhao L, Chen W, He L, Li X (2008) Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways. Biomed Pharmacother 62:383–389

    Article  CAS  Google Scholar 

  18. Zhang J, Zhang YM, Pan XY, Wang SC, He LC (2011) Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents. Med Chem 7:286–294

    Article  Google Scholar 

  19. Zhan Y, Li J, Ma W, Zhang D, Luo W (2016) Characterization of interactions between taspine derivate TPD7 and EGF receptor by cell membrane chromatography with zonal elution and frontal analysis, chromatographia. Chromatographia 79:1585–1592

    Article  CAS  Google Scholar 

  20. Zhan Y, Zhang H, Li J, Zhang Y, Zhang J, He LC (2015) A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR20. J Cell Mol Med 19:1614–1623

    Article  CAS  Google Scholar 

  21. Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L (2012) A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor alpha and EGF receptor signaling pathways. Cancer Prev Res 5:864–873

    Article  CAS  Google Scholar 

  22. Zhang J, Zhang Y, Shan Y, Li N, Ma W, He LC (2010) Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents. Eur J Med Chem 45:2798–2805

    Article  CAS  Google Scholar 

  23. Hou XF, Wang SC, Zhang T, Ma J, Zhang J, Zhang YM, Lu W, He HZ, He LC (2014) Recent advances in cell membrane chromatography for traditional Chinese medicines analysis. J Pharm Biomed 101:141–150

    Article  CAS  Google Scholar 

  24. Ma WY, Xie YY, Wang YM, Luo GA (2017) Emerging application and reflections of cell membrane chromatography in the quality evaluation of traditional Chinese medicine. Acta Pharmaceutica Sinica 52:1827–1838

    Google Scholar 

  25. Imai K, Tamura K, Tanigaki T, Takizawa M, Nakayama E, Taniguchi T, Okamoto M, Nishiyama Y, Tarumoto N, Mitsutake K, Murakami T, Maesaki S, Maeda T (2018) Whole genome sequencing of influenza A and B viruses with the MinION sequencer in the clinical setting: a pilot study. Front Microbiol 9:2748

    Article  Google Scholar 

  26. Chen XF, Cao Y, Zhang H, Zhu ZY, Liu M, Liu HB, Ding X, Hong ZY, Li WH, Lv DY, Wang LR, Zhuo XY, Zhang JP, Xie XQ, Chai YF (2014) Comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from Acontium carmichaeli. Anal Chem 86:4748–4757

    Article  CAS  Google Scholar 

  27. Du H, Wang S, Ren J, Lv N, He L (2012) Revealing multi-binding sites for taspine to VEGFR-2 by cell membrane chromatography zonal elution. J Chromatogr B 887–888:67–72

    Article  Google Scholar 

  28. Huang J, Tang Q, Wang C, Yu H, Feng Z, Zhu J (2015) Molecularly targeted therapy of human hepatocellular carcinoma xenografts with radio-iodinated anti-VEGFR2 Murine-human chimeric fab. Sci Rep 5:10660

    Article  Google Scholar 

  29. Hage DS, Noctor TA, Wainer IW (1995) Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin. J Chromatogr A 693:23–32

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by National Natural Science Foundation of China (Grant no. 81603148), the National Science Foundation for Post-doctoral Scientists of China (Grant no. 2016M592806), and the Fundamental Research Funds for the Central Universities (Grant no. xzy012019078).

Author information

Authors and Affiliations

  1. School of Pharmacy, Health Science Center, Xi’an Jiaotong University, No. 76, Yanta West Street, #54, Xi’an, 710061, Shaanxi, People’s Republic of China

    Liu Yang, Yingnan Zeng, Nan Ma & Weina Ma

  2. State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi’an, 710061, People’s Republic of China

    Weina Ma

Authors
  1. Liu Yang
    View author publications

    Search author on:PubMed Google Scholar

  2. Yingnan Zeng
    View author publications

    Search author on:PubMed Google Scholar

  3. Nan Ma
    View author publications

    Search author on:PubMed Google Scholar

  4. Weina Ma
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Weina Ma.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, L., Zeng, Y., Ma, N. et al. Interaction of Taspine Derivative TPD7 with Vascular Endothelial Growth Factor Receptor 2 by Cell Membrane Chromatography. Chromatographia 82, 1741–1748 (2019). https://doi.org/10.1007/s10337-019-03801-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-019-03801-1

Keywords